A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
Phase 1
60
about 1.5 years
35–75
2 sites in CA, MD
About this study
Researchers are testing a new medicine called NNC4004-0002 to see if it's safe when given to people with high uric acid levels who don't have any symptoms. The trial will involve giving participants either the medicine or a placebo (a harmless substance) by injection under their skin. Participants will be asked to visit the clinic for several appointments and may need to stay overnight at the clinic for one of these visits.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take NNC4004-0002
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Number of Treatment-emergent adverse event (TEAEs)
Secondary: AUC(0-72): The area under the NNC4004-0002 plasma concentration-time curve from time zero to the 72 hours after a single dose, Cmax: The maximum concentration of NNC4004-0002 in plasma, Renal clearance, tmax: The time from dose administration to the maximum plasma concentration of NNC4004-0002